Tag Archives: asset sales

Consolidation in the Pharma industry continues unabated

Posted on May 6, 2014 by Alexander Szewczak

As large assets swaps, mergers and acquisitions continue in the Pharma industry, Merck has announced it is selling its Consumer Care division to Bayer for $14B. The transaction will move Bayer into second place in consumer care, behind J&J. Merck … Continue reading →

Posted in Pharmaceutical Industry | Tagged , , , | Leave a comment